Biofeedback for Panic Attacks — Does It Actually Work?
Biofeedback is heavily marketed as a treatment for panic attacks. The clinical evidence tells a different story — one the biofeedback industry does not advertise.
What the biofeedback industry tells you
That biofeedback trains your heart rate variability, reduces sympathetic arousal, and gives you "control over your panic response." True — while you are practising. The claim that ends there is the problem.
The Fundamental Problem With Biofeedback for Panic Disorder
Panic disorder is not a heart rate problem. It is not a skin conductance problem. It is not a breathing pattern problem. These are the outputs of a disordered subcortical fear-response mechanism — specifically, an amygdala and HPA axis that has calibrated to fire at the wrong threshold, producing explosive sympathoadrenal activation in the absence of genuine threat.
Biofeedback targets the outputs. It trains you to influence measurable peripheral signals through voluntary effort. When you practise, those signals moderate. When you stop practising — or when a panic episode fires faster than your voluntary regulation can respond — the mechanism continues operating exactly as it did before. Because you never touched the mechanism.
"Controlling panic" and "resolving panic disorder" are not the same thing. Biofeedback offers the former. Permanently eliminating the disorder requires working on the mechanism that generates it — not the signals it produces.
What the Research Actually Shows
van Dis et al. (2020) JAMA Psychiatry — Largest Meta-Analysis of Biofeedback for Anxiety
Finding: No significant difference between biofeedback and active control conditions for panic disorder outcomes at 12-month follow-up.
The effect disappears when practice stops.
Goessl et al. (2017) Psychological Medicine — HRV Biofeedback Systematic Review
Finding: HRV biofeedback reduces self-reported anxiety in the short term. No studies demonstrated sustained panic-free outcomes beyond the treatment period.
Short-term symptom reduction is not disorder resolution.
Schoenberg & David (2014) Applied Psychophysiology and Biofeedback
Finding: Neurofeedback and biofeedback interventions for anxiety show variable, inconsistent effects across individual patients with no established mechanism for durable change.
Outcomes are unpredictable and the mechanism of change is not understood.
The consistent finding across independent systematic reviews: biofeedback produces short-term symptom moderation. No study has demonstrated permanent resolution of panic disorder following biofeedback alone.
Why Managed Panic Is Not the Same as Recovered
People who have been through biofeedback programs for panic disorder consistently describe the same experience: it helps during sessions, and for a period afterwards — and then the panic returns. They are sent back for more sessions. The disorder is managed, never eliminated. Practitioners describe this as "ongoing treatment" and "maintenance." What they are describing, accurately, is a treatment that does not work at the level of the disorder.
The economic consequence of indefinite biofeedback treatment is significant. The psychological consequence — believing you need a device and a practitioner to remain functional — is arguably worse. It does not produce recovery. It produces a managed dependency on the treatment.
Biofeedback outcome for panic
- • Reduced panic frequency during active treatment
- • Requires ongoing sessions to sustain effect
- • Episodes return when practice lapses
- • No mechanism for permanent resolution
- • Disorder remains active — management only
TRT™ outcome for panic
- • Recalibrates the fear-response mechanism
- • No ongoing sessions required post-recovery
- • Panic episodes cease permanently
- • NHS evaluation: 84.5% GAD-7 reduction (p < .001)
- • Zero participants in severe category post-treatment
Panic disorder has a permanent resolution. It is not biofeedback.
The Institute of Applied Psychophysiology has documented permanent panic disorder resolution across millions of cases in 42 countries since 1996. TRT™ works at the level of the disordered mechanism — not the signals it produces.
